A viral disease occurs when an individual is infected by a disease-causing microorganism called a virus (pathogen). A virus is a small organism that is capable of replicating inside the living host cell.

PART 01: Executive summary 6

PART 02: Research Methodology 22

PART 03: Introduction 25

Key market highlights 25

Key vendor offerings 26

PART 04: Disease Overview 30

Viral disease 30

PART 05: Market landscape 34

Market overview 34

Five forces analysis 37

PART 06: Pipeline analysis 38

PART 07: Market segmentation by therapies 43

Global hepatitis therapeutics market 43

Global HIV/AIDS therapeutics market 45

Global herpes therapeutics market 47

Global influenza therapeutics market 49

PART 08: Market segmentation by MOA 51

Reverse transcriptase inhibitors 51

Protease inhibitors 52

Entry/Fusion inhibitors 52

Immune system modulators 53

PART 09: Geographical segmentation 54

Antiviral drugs market in Americas 55

Antiviral drugs market in EMEA 57

Antiviral drugs market in APAC 59

PART 10: Decision framework 61

PART 11: Drivers and challenges 63

Market drivers 64

Impact of drivers on key customer segments 66

Market challenges 67

Forcefield analysis of impact of drivers and challenges 70

PART 12: Market trends 71

Technological advancements 71

Combination therapy 71

Mergers and acquisitions 72

Growing partnerships 73

PART 13: Competitive Landscape 74

Competitive scenario 74

PART 14: Key vendor analysis 77

Bristol-Myers Squibb 77

F. Hoffmann-La Roche 79

Gilead Sciences 82

GlaxoSmithKline 85

Other prominent vendors 87

PART 15: Appendix 89

List of abbreviations 89

PART 16: Explore Technavio 90